Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
detroit blog main
detroit top stories
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
novartis
bristol-myers squibb
cancer immunotherapy
clinical trials
fda
investing
ipo
nivolumab
startups
accent therapeutics
aducanumab
alexion pharmaceuticals
What
new
5
×
bio
roundup
companies
drug
ipo
life
science
activity
advantages
approval
approvals
bails
bar
biogen
biogen’s
biopharmaceutical
biotechs
brand
bridgebio
brings
capital
car
clamped
club
continued
convo
covid
crop
delays
develop
developing
drugs
earlier
economic
emerges
exceeded
expect
failures
fast
Language
unset
Current search:
new
×
cancer
×
" detroit top stories "
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M